Age-appropriate vaccination coverage and its determinants in children aged 12-36 months in Nepal: a national and

Santosh Kumar Rauniyar1, Yoko Iwaki2, Daisuke Yoneoka3,4

  • 1Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. rauniyar.sam@gmail.com.

BMC Public Health
|November 11, 2021
PubMed

Insights

Childhood vaccination in Nepal shows high crude coverage but low age-appropriate rates, undermining vaccine effectiveness. Timeliness monitoring and tailored provincial strategies are crucial for improving immunization coverage.

Area of Science:

  • Pediatrics
  • Public Health
  • Immunization Practices

Background:

  • Vaccination is vital for protecting children against life-threatening diseases.
  • Nepal's immunization program aims for high crude vaccine coverage.

Purpose of the Study:

  • To analyze age-appropriate vaccination coverage in Nepal at national and subnational levels.
  • To identify factors associated with timely vaccination in children.

Main Methods:

  • Analysis of data from 460 children (12-36 months) from the Nepal Demographic and Health Survey (NDHS) 2016-17.
  • Kaplan Meier method for estimating age-appropriate coverage of BCG, OPV, Pentavalent (PE), and MMR vaccines.
  • Multilevel logistic regression to identify factors associated with timely vaccination.

Main Results:

  • Crude vaccine coverage exceeded 90%, but age-appropriate coverage ranged from 41.5% to 73.9%.
  • Significant disparities in timely vaccination coverage were observed across provinces, with Province 2 and Province 6 showing the lowest rates.
  • Timeliness of vaccination was significantly associated with subnational regions and the season of childbirth.

Conclusions:

  • Despite high crude coverage, low age-appropriate vaccination rates in Nepal compromise vaccine effectiveness.
  • Monitoring vaccination timeliness alongside crude coverage is essential at all administrative levels.
  • Provincial governments must develop targeted strategies to improve timely childhood immunization.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
46.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
22
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
234
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
35
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
24
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21